{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:29:46Z","timestamp":1769606986356,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:00:00Z","timestamp":1419379200000},"content-version":"vor","delay-in-days":1606,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1111\/j.1469-0691.2009.03050.x","type":"journal-article","created":{"date-parts":[[2009,9,4]],"date-time":"2009-09-04T01:12:19Z","timestamp":1252026739000},"page":"1191-1196","source":"Crossref","is-referenced-by-count":28,"title":["High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia"],"prefix":"10.1016","volume":"16","author":[{"given":"M.","family":"Lafaurie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lapalu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Raffoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Touratier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2009.03050.x_bib1","first-page":"112","article-title":"Fungal infection and fever of unknown origin in neutropenic patients","volume":"80","author":"Bodey","year":"1986","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0268-960X(93)90007-Q","article-title":"Empiric amphotericin B therapy: the need for a reappraisal","volume":"7","author":"Fraser","year":"1993","journal-title":"Blood Rev"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-86-5-539","article-title":"Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response","volume":"86","author":"Aisner","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","article-title":"Empiric antifungal therapy in febrile granulocytopenic patients","volume":"86","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib6","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1200\/JCO.2000.18.12.2476","article-title":"Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients","volume":"18","author":"Cagnoni","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(82)90334-5","article-title":"Fungal infections in patients with acute leukaemia","volume":"73","author":"De Gregorio","year":"1982","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib11","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of aspergillosis infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejcsup.2007.06.005","article-title":"Empirical antifungal therapy in neutropenic cancer patients with persistent fever. Guidelines from the first European Conference on Infections in Leukaemia (ECIL)","volume":"5","author":"Marchetti","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer","volume":"108","author":"Winston","year":"2000","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B depxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib17","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.41.11.2326","article-title":"In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)","volume":"41","author":"Bartizal","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1111\/j.1469-0691.2009.03050.x_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2007.07.026","article-title":"Breathrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin","volume":"30","author":"Madureira","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib19","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.21615","article-title":"Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients","volume":"106","author":"Betts","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib21","unstructured":"Viscoli C, Herbrecht R, Akan H et al. Caspofungin (C) as First-line therapy of invasive aspergillosis (IA) in haematological patients (pts): a study of the EORTC Infectious Diseases Group. Abstract n\u00b0 O.12, 3rd TIMM, Torino: 2007."},{"key":"10.1111\/j.1469-0691.2009.03050.x_bib22","unstructured":"Herbrecht R, Maertens J, Baila L et al. Caspofungin as first-line therapy of invasive aspergillosis in allogeneic hematopoietic stem cell transplant recipients: a study of the EORTC infectious diseases group. Abstract M-2167. 48th ICAAC; Washington, DC: 2008."}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14642178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14642178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:56:50Z","timestamp":1558522610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14642178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1198743X14642178"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.03050.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}